Recent study showed that reduced level of IgG3 as a predictive marker in COVID‐19 patients characterized with postacute coronavirus disease 2019 (COVID‐19) syndrome (PACS) or long COVID‐19. This evidence concerns the gene IGHG3 and COVID-19.